U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07723833) titled 'A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants' on July 20.
Brief Summary: The purpose of this study is to measure the pharmacokinetics (PK-how the body processes the study drug) of elecoglipron in healthy participants when taken by mouth as different formulations.
Study Start Date: July 27
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Elecoglipron Reference Formulation Dose A
Elecoglipron tablets will be administered orally.
DRUG: Elecoglipron Test formulation 1 Dose A
Elecoglipron tablets will be adminis...